EUVIMEDEUVIMED entdecken
Crossref

A Phase 1/2 Study of TJO-083: A 5% Diquafosol Ophthalmic Formulation for the Treatment of Dry Eye Disease

Hyung Keun Lee, Tae-Im Kim, Jong Suk Song

Korean Journal of Ophthalmology · 10.08.2026

DOI: 10.3341/kjo.2026.0023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Korean Journal of Ophthalmology, online erschienen am 10.08.2026. Verfasst von Hyung Keun Lee und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea. shadik@yuhs.ac.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea. shadik@yuhs.ac.
  • Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, South Korea.
  • Department of Ophthalmology, Korea University College of Medicine, Seoul, South Korea.

Zitieren

APA

Lee, H. K., Kim, T. I., & Song, J. S. (2026). A Phase 1/2 Study of TJO-083: A 5% Diquafosol Ophthalmic Formulation for the Treatment of Dry Eye Disease. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2026.0023

Vancouver

Lee HK, Kim TI, Song JS. A Phase 1/2 Study of TJO-083: A 5% Diquafosol Ophthalmic Formulation for the Treatment of Dry Eye Disease. Korean Journal of Ophthalmology. 2026. doi:10.3341/kjo.2026.0023

BibTeX
@article{Lee2026,
  author = {Lee, Hyung Keun and Kim, Tae-Im and Song, Jong Suk},
  title = {A Phase 1/2 Study of TJO-083: A 5% Diquafosol Ophthalmic Formulation for the Treatment of Dry Eye Disease},
  journal = {Korean Journal of Ophthalmology},
  year = {2026},
  doi = {10.3341/kjo.2026.0023}
}
Kostenlos starten →